Kymera Therapeutics (KYMR) PT Raised to $38 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| (NASDAQ: KYMR) | Delayed: 119.33 -3.27 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $122.60 | 52 Week High | $ | |||
| Open | $122.58 | 52 Week Low | $ | |||
| Day High | $124.37 | P/E | N/A | |||
| Day Low | $117.31 | EPS | $ | |||
| Volume | 305,521 | |||||
